Reporting Checklist for Nature Neuroscience

Size: px
Start display at page:

Download "Reporting Checklist for Nature Neuroscience"

Transcription

1 Corresponding Author: Manuscript Number: Manuscript Type: Atsushi Miyawaki NNT51493A Technical Report Reporting Checklist Nature Neuroscience # Main Figures: 7 # Supplementary Figures: 12 # Supplementary Tables: 3 # Supplementary Videos: 2 This checklist is used to ensure good reporting stards to improve the reproducibility of published results. For more inmation, please read Reporting Life Sciences Research. Please note that in the event of publication, it is matory that authors include all relevant methodological statistical inmation in the manuscript. Statistics reporting, by figure example example Please specify the following inmation each panel reporting quantitative data, where each item is reported (section, e.g. Results, paragraph number). Each figure should ideally contain an exact sample size (n) each experimental group/condition, where n is an exact number not a range, a clear definition of how n is defined ( example x cells from x slices from x animals from x litters, collected over x days), a description of the statistical test used, the results of the tests, any descriptive statistics clearly defined error bars if applicable. For any experiments using custom statistics, please indicate the test used stats obtained each experiment. Each figure should include a statement of how many times the experiment shown was replicated in the lab; the details of sample collection should be sufficiently clear so that the replicability of the experiment is obvious to the reader. For experiments reported in the text but not in the figures, please use the paragraph number instead of the figure number. Note: Mean stard deviation are not appropriate on small samples, plotting independent data points is usually more inmative. When technical replicates are reported, error significance measures reflect the experimental variability not the variability of the biological process; it is misleading not to state this clearly. FIGURE NUMBER 1a results, TEST USED WHICH TEST? oneway ANOVA unpaired t test SECTION Fig. Results EXACT VALUE 9, 9, 10, 15 n DEFINED? mice from at least 3 litters/group 15 slices from 10 mice SECTION Methods para 8 Results DESCRIPTIVE STATS (AVERAGE, VARIANCE) REPORTED? error bars are mean / SEM error bars are mean / SEM SECTION Fig. Results P VALUE EXACT VALUE SECTION Fig. Results DEGREES OF FREEDOM F/t/z/R/ETC VALUE VALUE F(3, 36) = 2.97 t(28) = SECTION Fig. Results 1

2 FIGURE NUMBER 2b 2b TEST USED WHICH TEST? Oneway ANOVA with Bonferroni's multiple s test Oneway ANOVA with Bonferroni's multiple s test SECTION Fig,2 Fig,2 EXACT VALUE 9, 6, 4, 4 9, 6, 4, 4 n DEFINED? transmittance ScaleStreated hemispheres(9) CUBICtreated(6), 3DISCOtreated(4), or SeeDBtreated(4) hemispheres. normalized YFP fluorescence ScaleStreated hemispheres(9) CUBICtreated(6), 3DISCOtreated(4), or SeeDBtreated(4) hemispheres. SECTION Fig. 2 Fig. 2 DESCRIPTIVE STATS (AVERAGE, VARIANCE) REPORTED? mean / SD mean / SD SECTION Fig. 2 Fig. 2 P VALUE EXACT VALUE [Oneway ANOVA] E15 [Bonferroni test] E6 ScaleS CUBIC E11 ScaleS 3DISCO E10 ScaleS SeeDB [Oneway ANOVA] E11 [Bonferroni test] E10 ScaleS CUBIC E11 ScaleS 3DISCO E7 ScaleS SeeDB SECTION DEGREES OF FREEDOM F/t/z/R/ETC VALUE VALUE [Oneway ANOVA] F(3, 20)= [Bonferroni test] t = ScaleS CUBIC. t = ScaleS 3DISCO. t = ScaleS SeeDB. [Oneway ANOVA] F(3, 20)= [Bonferroni test] t = ScaleS CUBIC. t = ScaleS 3DISCO. t = ScaleS SeeDB. SECTION 2

3 2d 2d 3y S 10d S Tab3 S Tab3 Welch's unpaired ttest, twotailed Welch's unpaired ttest, twotailed Mann Whitney's Utest Welch's unpaired ttest, twotailed Welch's unpaired ttest, twotailed Welch's unpaired ttest, twotailed Fig,2 Fig,2 Fig.10 6, 7 6, 7 6, 8 10, 10 3, 6 3, 9 transmittance ScaleStreated brain slices(6) PACTtreated brain slices(7). normalized YFP fluorescence ScaleStreated brain slices(6) PACTtreated brain slices(7). presynaptic fabric postsynaptic fabric ScaleS PBS( ) treated brain hemispheres. Six regions from 3 mice (ScaleS). Eight regions from 3 mice (PBS( )). synaptic density inside outside amyloid plaques. Ten areas from a 24monthsold (APPknockin) mouse brain were analyses. Density of diffuse amyloid plaques in AD patient brains. diffuse plaque density cored plaque () samples (3) cored plaque ( ) samples (6). microglial association cored plaques (3) diffuse plaques (9). Nine AD patient samples were used. Diffuse plaques were found in all 9 samples.; cored plaques were found in 3 of 9. Fig. 2 Fig. 10 Fig. 10 mean / SD mean / SD mean / SEM mean / SEM mean / SD mean / SD Fig. 10 Fig.10 Table 3 Table P = E4 For presynaptic fabric: For postsynaptic fabric: Fig.10 t = df = t = df = For presynaptic fabric: U=11 Z= For postsynaptic fabric: U=9.5 Z= t = 4.807, df = 18 t = , df = t = df = Fig.10 3

4 Representative figures 1. Are any representative images shown (including Western blots immunohistochemistry/staining) in the paper? If so, what figure(s)? (Main Figs) <Fig.1a,b> At least 3 different samples were examined each condition. <Fig. 1d,e> See Fig. 2 Fig. 3. <Fig. 2a, c> Representative images (#1) are shown. All the images other than #1 are shown in Supplementary Fig. 3. <Fig. 3a x> See Table 2. <Fig. 4b h> The same results were obtained from another AppNLF/NLF mouse (20 months old). <Fig. 5a,b> Observation from different angles revealed that plaques were mostly located in the cerebral cortex. <Fig. 5d> A similar movie was created using another 20monthold AppNLF/ NLF mouse. <Fig.5e h> See Fig. 10. <Fig. 5in> More than 3 single plaques were successfully tracked from hemispheres of 2 different animals. <Fig.6b h> Similar images were obtained from 3 other AppNLF/NLF mice (10, 12, 14 month old) (See Fig. 11). <6j,k> See. <6n q> See. <Fig.7a l> Similar results were obtained using 11 6 mice ScaleSQ(0) ScaleSQ(5) experiments, respectively. (Supplementary Figs) <Supplementary Fig. 5> The experiment was permed in triplicate each using different mouse brains. <Supplementary Fig. 6a f> Similar TEM images were obtained from 3 other mice of the same age. <Supplementary Fig. 6g i> Similar TEM images were obtained from 3 other mice of the same age. <Supplementary Fig. 9b> Similar results were obtained with another cube from #1625. <Supplementary Fig. 10a c> Three representative images of 10. 4

5 2. For each representative image, is there a clear statement of how many times this experiment was successfully repeated a discussion of any limitations in repeatability? If so, where is this reported (section, paragraph #)? Statistics general methods 1. Is there a justification of the sample size? If so, how was it justified? Even if no sample size calculation was permed, authors should report why the sample size is adequate to measure their effect size. 2. Are statistical tests justified as appropriate every figure? a. If there is a section summarizing the statistical methods in the methods, is the statistical test each experiment clearly defined? b. Do the data meet the assumptions of the specific statistical test you chose (e.g. normality a parametric test)? Where is this described (section, paragraph #)? c. Is there any estimate of variance within each group of data? Is the variance similar groups that are being statistically compared? Where is this described (section, paragraph #)? In the s of the abovementioned figures, supplementary figures, supplementary tables. The sample size was determined by the availability of Tg mice (YFP H ChR2YFP) or APP knockin mice. No statistical methods were used to predetermine sample sizes, but our sample sizes (n > 3 mice per group imaging analysis) are similar to those generally used in this field. When N = 2 or 3, individual data are shown (e.g., Fig. 8). Yes, they are justified in "Statistical analysis" in the Online Methods, indicated in the s of Fig. 2, Fig. 3, Supplementary Fig. 10, Supplementary Table. 3. Also, a correlation coefficient is shown in Supplementary Fig.7b. Yes, there is a section "Statistical analysis" in the Online Methods. Yes, the statistical test each experiment is defined in the. The distribution of data in each experiment was checked normality /or equal variation. In the section "Statistical analysis" in the Online Methods. Yes, the variance of each data group is shown with the stard deviation (S.D.) or stard error of mean (S.E.M.). Yes, equal variation was checked. In the s of Fig. 2, Fig. 3, Supplementary Fig. 10, Supplementary Table. 3. d. Are tests specified as one or twosided? Unpaired ttest was used twogroup in Fig. 2 Supplementary Fig. 10 Supplementary Table. 3. Both tests are specified as twosided. e. Are there adjustments multiple s? Yes, Bonferroni adjustments were used. 3. Are criteria excluding data points reported? Was this criterion established prior to data collection? Where is this described (section, paragraph #)? 4. Define the method of romization used to assign subjects (or samples) to the experimental groups to collect process data. If no romization was used, state so. No. There are no data excluded. No romization of mice or samples was used prior to analysis. Where does this appear (section, paragraph #)? 5

6 5. Is a statement of the extent to which investigator knew the group allocation during the experiment in assessing outcome included? If no blinding was done, state so. 6. For experiments in live vertebrates, is a statement of compliance with ethical guidelines/regulations included? 7. Is the species of the animals used reported? 8. Is the strain of the animals (including background strains of KO/ transgenic animals used) reported? 9. Is the sex of the animals/subjects used reported? 10. Is the age of the animals/subjects reported? 11. For animals housed in a vivarium, is the light/dark cycle reported? 12. For animals housed in a vivarium, is the housing group (i.e. number of animals per cage) reported? 13. For behavioral experiments, is the time of day reported (e.g. light or dark cycle)? 14. Is the previous history of the animals/subjects (e.g. prior drug administration, surgery, behavioral testing) reported? When evaluating different methods comparatively, the analyzers were blinded to all conditions during data analysis. In "Statistical analysis" of the Online Methods. The experimental procedures housing conditions animals were approved by the Institute s Animal Experiments Committee all animals were cared treated humanely in accordance with the Institutional Guidelines Experiments using animals. This is stated in the Online Methods section: Mouse lines. In the Online Methods section Figure Legends. In the Online Methods section: Mouse lines, Figure Legends. A general statement is made in the Online Methods section: Mouse lines. For mouse brain study, the gender inmation is shown in Fig. 2 Supplementary Fig. 3. For human postmortem study, the gender inmation is shown in Fig. 6 Supplementary. Yes, the age is always specified in all display items their s. Very often in the main text too. Mice were housed under 12 hrs light/12 hrs dark cycle, the statement is made in the Online Methods section: Mouse lines. Five mice per cage. In the Online Methods section: Mouse lines. 6

7 a. If multiple behavioral tests were conducted in the same group of animals, is this reported? 15. If any animals/subjects were excluded from analysis, is this reported? Reagents a. How were the criteria exclusion defined? Where is this described (section, paragraph #)? b. Specify reasons any discrepancy the number of animals at the beginning end of the study. Where is this described (section, paragraph #)? 1. Have antibodies been validated use in the system under study (assay species)? a. Is antibody catalog number given? Where does this appear (section, paragraph #)? b. Where were the validation data reported (citation, supplementary inmation, Antibodypedia)? Where does this appear (section, paragraph #)? 2. If cell lines were used to reflect the properties of a particular tissue or disease state, is their source identified? Male mice (wildtype, C57BL/6J) were used examining clearing capability ultrastructure preservation of methods. Otherwise, no animal exclusion was made. In the online Methods: Mouse lines. The antibodies used 3Dimmunohistochemistry (3DIHC) were validated by 2DIHC that used cryosections prepared from C57BL/6J or APP(NLF/NLF) mouse brain tissues AD patient brain tissues. Their catalog number are given in the Online Methods section (see Immunohistochemistry). The mouse monoclonal antiamyloid beta antibody (clone 6E10) was validated by Vidal et al. [FASEB J 26, (2012)]. The mouse monoclonal antineun antibody (clone A60) was validated by Zhu et al. [J. Neurosci. 23, (2003)]. The rabbit polyclonal antiiba1 antibody was validated by Yoshikawa et al. [Plos ONE 5 e13932 (2010)]. These papers are cited in the Online Methods section. The validation data of the rabbit polyclonal antineun antibody was given by the Millipore (URL:http: product/antineun%28rabbit%29antibody,mm_nfabn78? iscountryemd=yes). Rabbit polyclonal antivglut1 serum, rabbit polyclonal antiglur1 antibody, mouse monoclonal antipsa NCAM antibody (clone 22B) were validated in our previous paper [Hama et al. Nat. Neurosci. 14, (2011)]. Other antibodies, rabbit polyclonal antimap2 antibody (Millipore, Chemicon), mouse monoclonal antigfap antibody [clone GA5 (Sigma)], mouse monoclonal antisynaptophysin antibody [clone SVP38 (Synaptic Systems)], rabbit polyclonal antisv2a serum (Synaptic Systems), mouse monoclonal antiglur2 antibody [clone 6C4 (Millipore Chemicon)] were validated by their suppliers via product specification data. 7

8 a. Were they recently authenticated? Where is this inmation reported (section, paragraph #)? Data deposition Data deposition in a public repository is matory : a. Protein, DNA RNA sequences b. Macromolecular structures c. Crystallographic data small molecules d. Microarray data Deposition is strongly recommended many other datasets which structured public repositories exist; more details on our data policy are available here. We encourage the provision of other source data in supplementary inmation or in unstructured repositories such as Figshare Dryad. We encourage publication of Data Descriptors (see Scientific Data) to maximize data reuse. 1. Are accession codes deposit dates provided? Computer code/software Any custom algorithm/software that is central to the methods must be supplied by the authors in a usable readable m readers at the time of publication. However, referees may ask this inmation at any time during the review process. 1. Identify all custom software or scripts that were required to conduct the study where in the procedures each was used. 2. If computer code was used to generate results that are central to the paper's conclusions, include a statement in the Methods section under "Code availability" to indicate whether how the code can be accessed. Include version inmation as necessary any restrictions on availability. Human subjects 1. Which IRB approved the protocol? Where is this stated (section, paragraph #)? Open CV Threshold is stated in the Online Methods section: Image Segmentation, it was used in the experiments Fig. 5, Fig. 6, Supplementary Fig. 11. Distance Calculation from Volocity is stated in the Methods section: Measurement of distances, it was used in the experiments Fig. 6 Supplementary Fig D Reslicer is stated in the Online Methods section: Image reslicing in the zaxis, it was used in the experiments Fig. 6 Supplementary Fig. 11. Jinarashi is cited in the Online Methods section: Image segmentation, it was used 3D volume rendering in the experiments Fig. 5a, b, d, Fig. 6b h, 6i l, 6n r, Supplementary Fig. 11b d. Computer code was not used. The software programs "Image segmentation", "Measurement of 3D distances", "Image reslicing in the zaxis" are available upon request (stated in the Online Methods). The hling ethics human specimens were approved by the Institute s Research Ethics Committee all the human tissues were cared treated in accordance with the Institutional Guidelines Experiments with Human Specimens (RIKEN). This is stated in the Online Methods section (see "Human sample preparation"). 8

9 2. Is demographic inmation on all subjects provided? 3. Is the number of human subjects, their age sex clearly defined? 4. Are the inclusion exclusion criteria (if any) clearly specified? 5. How well were the groups matched? Where is this inmation described (section, paragraph #)? 6. Is a statement included confirming that inmed consent was obtained from all subjects? 7. For publication of patient photos, is a statement included confirming that consent to publish was obtained? fmri studies No. We examined postmortem brain tissues of Alzheimer's disease patients. The inmation of age sex is provided in Fig. 6, Supplementary. For papers reporting functional imaging (fmri) results please ensure that these minimal reporting guidelines are met that all this inmation is clearly provided in the methods: 1. Were any subjects scanned but then rejected the analysis after the data was collected? a. If yes, is the number rejected reasons rejection described? 2. Is the number of blocks, trials or experimental units per session / or subjects specified? 3. Is the length of each trial interval trials specified? 4. Is a blocked, eventrelated, or mixed design being used? If applicable, please specify the block length or how the eventrelated or mixed design was optimized. 9

10 5. Is the task design clearly described? 6. How was behavioral permance measured? 7. Is an ANOVA or factorial design being used? 8. For data acquisition, is a whole brain scan used? If not, state area of acquisition. a. How was this region determined? 9. Is the field strength (in Tesla) of the MRI system stated? a. Is the pulse sequence type (gradient/spin echo, EPI/spiral) stated? b. Are the fieldofview, matrix size, slice thickness, TE/TR/ flip angle clearly stated? 10. Are the software specific parameters (model/functions, smoothing kernel size if applicable, etc.) used data processing preprocessing clearly stated? 11. Is the coordinate space the anatomical/functional imaging data clearly defined as subject/native space or stardized stereotaxic space, e.g., original Talairach, MNI305, ICBM152, etc? Where (section, paragraph #)? 12. If there was data normalization/stardization to a specific space template, are the type of transmation (linear vs. nonlinear) used image types being transmed clearly described? Where (section, paragraph #)? 13. How were anatomical locations determined, e.g., via an automated labeling algorithm (AAL), stardized coordinate database (Talairach daemon), probabilistic atlases, etc.? 14. Were any additional regressors (behavioral covariates, motion etc) used? 15. Is the contrast construction clearly defined? 16. Is a mixed/rom effects or fixed inference used? a. If fixed effects inference used, is this justified? 17. Were repeated measures used (multiple measurements per subject)? 10

11 a. If so, are the method to account within subject correlation the assumptions made about variance clearly stated? 18. If the threshold used inference visualization in figures varies, is this clearly stated? 19. Are statistical inferences corrected multiple s? a. If not, is this labeled as uncorrected? 20. Are the results based on an ROI (region of interest) analysis? a. If so, is the rationale clearly described? b. How were the ROI s defined (functional vs anatomical localization)? 21. Is there correction multiple s within each voxel? 22. For clusterwise significance, is the clusterdefining threshold the corrected significance level defined? Additional comments Additional Comments 11

Reporting Checklist for Nature Neuroscience

Reporting Checklist for Nature Neuroscience Corresponding Author: Manuscript Number: Manuscript Type: Leonard Petrucelli NNA52530C Article Reporting Checklist for Nature Neuroscience # Main s: 8 # Supplementary s: 10 # Supplementary Tables: 3 #

More information

Reporting Checklist for Nature Neuroscience

Reporting Checklist for Nature Neuroscience Corresponding Author: Manuscript Number: Manuscript Type: McColl NNRS50586AZ Resource Reporting Checklist for Nature Neuroscience # Main Figures: 8 # lementary Figures: 7 # lementary Tables: 13 # lementary

More information

Reporting Checklist for Nature Neuroscience

Reporting Checklist for Nature Neuroscience Corresponding Author: Manuscript Number: Manuscript Type: xiangdong fu, yuanchao xue NNA52804A Article Reporting Checklist Nature Neuroscience # Main Figures: 5 # Supplementary Figures: 7 # Supplementary

More information

Reporting Checklist for Nature Neuroscience

Reporting Checklist for Nature Neuroscience Corresponding Author: Manuscript Number: Manuscript Type: Michael Cole NNA51 Article Reporting Checklist for Nature Neuroscience # Main Figures: 5 # lementary Figures: 4 # lementary Tables: 0 # lementary

More information

Reporting Checklist for Nature Neuroscience

Reporting Checklist for Nature Neuroscience Corresponding Author: Manuscript Number: Manuscript Type: Feltri NNA54268B Article Reporting Checklist for Nature Neuroscience # Main Figures: 7 # Supplementary Figures: 5 # Supplementary Tables: 1 # Supplementary

More information

Reporting Checklist for Nature Neuroscience

Reporting Checklist for Nature Neuroscience Corresponding Author: Manuscript Number: Manuscript Type: Liu NNA52890T Article Reporting Checklist for Nature Neuroscience # Main Figures: 4 # Supplementary Figures: 3 # Supplementary Tables: 1 # Supplementary

More information

Reporting Checklist for Nature Neuroscience

Reporting Checklist for Nature Neuroscience Corresponding Author: Manuscript Number: Manuscript Type: Chay T. Kuo NNA47008 Article Reporting Checklist for Nature Neuroscience # Main Figures: 7 # Supplementary Figures: 11 # Supplementary Tables:

More information

Reporting Checklist for Nature Neuroscience

Reporting Checklist for Nature Neuroscience Corresponding Author: Manuscript Number: Manuscript Type: Yang Dan NNA56598 Article Reporting Checklist for Nature Neuroscience # Main Figures: 8 # Supplementary Figures: 12 # Supplementary Tables: 0 #

More information

Reporting Checklist for Nature Neuroscience

Reporting Checklist for Nature Neuroscience Corresponding Author: Manuscript Number: Manuscript Type: Rachel Wilson NNA48246B Article Reporting Checklist for Nature Neuroscience # Main Figures: 8 # Supplementary Figures: 7 # Supplementary Tables:

More information

Reporting Checklist for Nature Neuroscience

Reporting Checklist for Nature Neuroscience Corresponding Author: Manuscript Number: Manuscript Type: David Dupret NNBC5329A Brief Communication Reporting Checklist for Nature Neuroscience # s: 3 # s: 11 # Tables: 0 # Videos: 0 This checklist is

More information

Reporting Checklist for Nature Neuroscience

Reporting Checklist for Nature Neuroscience Corresponding Author: Manuscript Number: Manuscript Type: Robert Froemke NNA7412T Article Reporting Checklist for Nature Neuroscience # Main s: 7 # Supplementary s: 14 # Supplementary Tables: 0 # Supplementary

More information

Reporting Checklist for Nature Neuroscience

Reporting Checklist for Nature Neuroscience Corresponding Author: Manuscript Number: Manuscript Type: Lennart Mucke NNRS49607AZ Resource Reporting Checklist for Nature Neuroscience # Main s: # lementary s: 4 # lementary Tables: 9 # lementary Videos:

More information

Reporting Checklist for Nature Neuroscience

Reporting Checklist for Nature Neuroscience Corponding Author: Manuscript Number: Manuscript Type: Gregory C. DeAngelis NNA49009A Article Reporting Checklist for Nature Neuroscience # Main Figu: 7 # lementary Figu: # lementary Tables: 0 # lementary

More information

Reporting Checklist for Nature Neuroscience

Reporting Checklist for Nature Neuroscience Corresponding Author: Manuscript Number: Manuscript Type: RuRong Ji NNA59063A Article Reporting Checklist for Nature Neuroscience # Main ures: 8 # Supplementary ures: 15 # Supplementary Tables: 0 # Supplementary

More information

Reporting Checklist for Nature Neuroscience

Reporting Checklist for Nature Neuroscience Corresponding Author: Manuscript Number: Manuscript Type: Hillel Adesnik NNA58169T Article Reporting Checklist for Nature Neuroscience # Main ures: 5 # lementary ures: 6 # lementary Tables: 1 # lementary

More information

Reporting Checklist for Nature Neuroscience

Reporting Checklist for Nature Neuroscience Corresponding Author: Marcelo Coba Manuscript Number: NNRS3314D Manuscript Type: Resource Reporting Checklist for Nature Neuroscience # Main Figures: 7 # lementary Figures: 4 # lementary Tables: 11 # lementary

More information

Reporting Checklist for Nature Neuroscience

Reporting Checklist for Nature Neuroscience Corresponding Author: Manuscript Number: Manuscript Type: Ofer Yizhar, PhD NNA54616C Article Reporting Checklist for Nature Neuroscience # Main s: 5 # lementary s: 10 # lementary Tables: 0 # lementary

More information

Reporting Checklist for Nature Neuroscience

Reporting Checklist for Nature Neuroscience Corresponding Author: Manuscript Number: Manuscript Type: Benjamin R. Rost NNT51693 Technical Report Reporting Checklt for Nature Neuroscience # Main Figures: 6 # Supplementary Figures: 9 # Supplementary

More information

Reporting Checklist for Nature Neuroscience

Reporting Checklist for Nature Neuroscience Correspondg Author: Manuscript Number: Manuscript Type: Spencer Smith NNA48000A Article Reportg Checklist for Nature Neuroscience # Ma Figures: 6 # Supplementary Figures: 8 # Supplementary Tables: 1 #

More information

Our web collection on statistics for biologists may be useful.

Our web collection on statistics for biologists may be useful. Reporting Summary Corresponding author(s): FELIPE CAVA Nature Research wishes to improve the reproducibility of the work that we publish. This form provides structure for consistency and transparency in

More information

Life Sciences Reporting Summary

Life Sciences Reporting Summary Life Sciences Reporting Summary Adams Waldorf, Rajagopal, Gale Initial submission Revised version Final submission Nature Research wishes to improve the reproducibility of the work that we publish. This

More information

Life Sciences Reporting Summary

Life Sciences Reporting Summary Life Sciences Reporting Summary Corresponding author(s): Rich, Jeremy N. Initial submission Revised version Final submission Nature Research wishes to improve the reproducibility of the work that we publish.

More information

Jeffrey W. Elias, PhD UCD SOM Office of Research Grants Facilitation.

Jeffrey W. Elias, PhD UCD SOM Office of Research Grants Facilitation. NIH IS CHANGING/ENHANCING THE REVIEW CRITERIA AND FOCUSING ON MISSING OPPORTUNITIES TO EXAMINE SEX DIFFERENCES JOURNALS ARE CHANGING/ENHANCING THE REVIEW CRITERIA Jeffrey W. Elias, PhD UCD SOM Office of

More information

Efforts to Improve Data Transparency at the JBC

Efforts to Improve Data Transparency at the JBC Efforts to Improve Data Transparency at the JBC Roger J. Colbran Associate Editor Credit: Amanda Fosang, Associate Editor 2 Why Improve Transparency? Irreproducibility of pre-clinical studies Negative

More information

Supplementary Figure 1. Screening for monoclonal antibodies against GluA1 by immunoblotting.

Supplementary Figure 1. Screening for monoclonal antibodies against GluA1 by immunoblotting. Supplementary Figure 1 Screening for monoclonal antibodies against GluA1 by immunoblotting. Hippocampal extract was subjected to western blotting with the hybridoma supernatants of candidate monoclonal

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION SUPPLEMENTARY INFORMATION DOI: 10.1038/ncb3575 In the format provided by the authors and unedited. Supplementary Figure 1 Validation of key reagents and assays a, top, IHC with antibody recognizing specifically

More information

BIOEQUIVALENCE TRIAL INFORMATION FORM (Medicines and Allied Substances Act [No. 3] of 2013 Part V Section 39)

BIOEQUIVALENCE TRIAL INFORMATION FORM (Medicines and Allied Substances Act [No. 3] of 2013 Part V Section 39) ZAMRA BTIF BIOEQUIVALENCE TRIAL INFORMATION FORM (Medicines and Allied Substances Act [No. 3] of 2013 Part V Section 39) The Guidelines on Bioequivalence Studies to be consulted in completing this form.

More information

BIOEQUIVALENCE TRIAL INFORMATION

BIOEQUIVALENCE TRIAL INFORMATION PRESENTATION OF BIOEQUIVALENCE TRIAL INFORMATION BIOEQUIVALENCE TRIAL INFORMATION GENERAL INSTRUCTIONS: Please review all the instructions thoroughly and carefully prior to completing the Bioequivalence

More information

Cerebrospinal fluid tau, neurogranin and neurofilament light in Alzheimerís disease

Cerebrospinal fluid tau, neurogranin and neurofilament light in Alzheimerís disease Cerebrospinal fluid tau, neurogranin and neurofilament light in Alzheimerís disease Niklas Mattsson, Philip Insel, Sebastian Palmqvist, Erik Portelius, Henrik Zetterberg, Michael Weiner, Kaj Blennow, Oskar

More information

Life Sciences Reporting Summary

Life Sciences Reporting Summary Life Sciences Reporting Summary Corresponding author(s): Stein Aerts Initial submission Revised version Final submission Nature Research wishes to improve the reproducibility of the work that we publish.

More information

Precision in Quantitative Imaging: Trial Development and Quality Assurance

Precision in Quantitative Imaging: Trial Development and Quality Assurance Precision in Quantitative Imaging: Trial Development and Quality Assurance Susanna I Lee MD, PhD Thanks to: Mitchell Schnall, Mark Rosen. Dan Sullivan, Patrick Bossuyt Imaging Chain: Patient Data Raw data

More information

PROMOTING TRANSPARENT RESEARCH METHODS, PROTOCOLS AND DATA TO REDUCE IRREPRODUCIBILITY

PROMOTING TRANSPARENT RESEARCH METHODS, PROTOCOLS AND DATA TO REDUCE IRREPRODUCIBILITY PROMOTING TRANSPARENT RESEARCH METHODS, PROTOCOLS AND DATA TO REDUCE IRREPRODUCIBILITY December 2015 STM Innovations Seminar Andrew L Hufton, PhD Managing Editor, Scientific Data Nature Publishing Group

More information

Medicines Control Authority Of Zimbabwe

Medicines Control Authority Of Zimbabwe Medicines Control Authority Of Zimbabwe BIOEQUIVALENCE APPLICATION FORM Form: EVF03 This application form is designed to facilitate information exchange between the Applicant and the MCAZ for bioequivalence

More information

Revision Checklist for Science Signaling Research Manuscripts: Data Requirements and Style Guidelines

Revision Checklist for Science Signaling Research Manuscripts: Data Requirements and Style Guidelines Revision Checklist for Science Signaling Research Manuscripts: Data Requirements and Style Guidelines Further information can be found at: http://stke.sciencemag.org/sites/default/files/researcharticlerevmsinstructions_0.pdf.

More information

David M. Rocke Division of Biostatistics and Department of Biomedical Engineering University of California, Davis

David M. Rocke Division of Biostatistics and Department of Biomedical Engineering University of California, Davis David M. Rocke Division of Biostatistics and Department of Biomedical Engineering University of California, Davis Outline RNA-Seq for differential expression analysis Statistical methods for RNA-Seq: Structure

More information

Our web collection on statistics for biologists may be useful.

Our web collection on statistics for biologists may be useful. Reporting Summary Corresponding author(s): Qi-jing Li, Lilin Ye and Bo Zhu Nature Research wishes to improve the reproducibility of the work that we publish. This form provides structure for consistency

More information

Edinburgh Research Explorer

Edinburgh Research Explorer Edinburgh Research Explorer Protocol for a retrospective, controlled cohort study of the impact of a change in Nature journals' editorial policy for life sciences research on the completeness of reporting

More information

Life Sciences Reporting Summary

Life Sciences Reporting Summary Life Sciences Reporting Summary Corresponding author(s): Christer Betsholtz Initial submission Revised version Final submission Nature Research wishes to improve the reproducibility of the work that we

More information

Supplementary Figure 1. α-synuclein is truncated in PD and LBD brains. Nature Structural & Molecular Biology: doi: /nsmb.

Supplementary Figure 1. α-synuclein is truncated in PD and LBD brains. Nature Structural & Molecular Biology: doi: /nsmb. Supplementary Figure 1 α-synuclein is truncated in PD and LBD brains. (a) Specificity of anti-n103 antibody. Anti-N103 antibody was coated on an ELISA plate and different concentrations of full-length

More information

Reporting Summary. Statistical parameters. Software and code. nature research reporting summary April Corresponding author(s):

Reporting Summary. Statistical parameters. Software and code. nature research reporting summary April Corresponding author(s): Reporting Summary Corresponding author(s): Alexander Flügel 2018-07-09758C Nature Research wishes to improve the reproducibility of the work that we publish. This form provides structure for consistency

More information

A normal genetic variation modulates synaptic MMP-9 protein levels and the severity of schizophrenia symptoms

A normal genetic variation modulates synaptic MMP-9 protein levels and the severity of schizophrenia symptoms A normal genetic variation modulates synaptic MMP-9 protein levels and the severity of schizophrenia symptoms Katarzyna Lepeta, Katarzyna J. Purzycka, Katarzyna Pachulska-Wieczorek, Marina Mitjans, Martin

More information

iphemap: An atlas of Phenotype to genotype relationships of human ipsc models of neurological diseases

iphemap: An atlas of Phenotype to genotype relationships of human ipsc models of neurological diseases iphemap: An atlas of Phenotype to genotype relationships of human ipsc models of neurological diseases Ethan W. Hollingsworth, Jacob E. Vaughn, Josh C. Orack, Chelsea Skinner, Jamil Khouri, Sofia B. Lizarraga,

More information

A Comparison of AlphaLISA and TR-FRET Homogeneous Immunoassays in Serum-Containing Samples

A Comparison of AlphaLISA and TR-FRET Homogeneous Immunoassays in Serum-Containing Samples application Note A Comparison of and Homogeneous Immunoassays in Serum-Containing Samples Authors Anuradha Prasad, PhD, Catherine Lautenschlager, PhD, Stephen Hurt, PhD, David Titus, PhD and Stéphane Parent,

More information

CHAPTER 17 Brain Image Analysis and Atlas Construction

CHAPTER 17 Brain Image Analysis and Atlas Construction CHAPTER 17 Brain Image Analysis and Atlas Construction Paul M. Thompson Michael S. Mega Katherine L. Narr Elizabeth R. Sowell Rebecca E. Blanton Arthur W. Toga Contents 17.1 Challenges in brain image analysis

More information

Nature Methods: doi: /nmeth Supplementary Figure 1. Retention of RNA with LabelX.

Nature Methods: doi: /nmeth Supplementary Figure 1. Retention of RNA with LabelX. Supplementary Figure 1 Retention of RNA with LabelX. (a) Epi-fluorescence image of single molecule FISH (smfish) against GAPDH on HeLa cells expanded without LabelX treatment. (b) Epi-fluorescence image

More information

Methods in Clinical Cancer Research Workshop Format for Protocol Concept Synopsis Sheet (blank) SYNOPSIS

Methods in Clinical Cancer Research Workshop Format for Protocol Concept Synopsis Sheet (blank) SYNOPSIS B Methods in Clinical Cancer Research Workshop Format for Protocol Concept Synopsis Sheet (blank) elow is the format to follow for the concept sheet for protocols. It is based on the International Committee

More information

Supplementary Information

Supplementary Information Supplementary Information Figure S1. Transiently overexpressed ECFP-TIAF1/EYFP-TIAF1 causes apoptosis of Mv1Lu cells. Mv1Lu cells were transfected by electroporation with ECFP, EYFP, ECFP-TIAF1, EYFP-

More information

Supplementary Figure 1. APP cleavage assay. HEK293 cells were transfected with various

Supplementary Figure 1. APP cleavage assay. HEK293 cells were transfected with various Supplementary Figure 1. APP cleavage assay. HEK293 cells were transfected with various GST-tagged N-terminal truncated APP fragments including GST-APP full-length (FL), APP (123-695), APP (189-695), or

More information

Validation of Analytical Methods used for the Characterization, Physicochemical and Functional Analysis and of Biopharmaceuticals.

Validation of Analytical Methods used for the Characterization, Physicochemical and Functional Analysis and of Biopharmaceuticals. Validation of Analytical Methods used for the Characterization, Physicochemical and Functional Analysis and of Biopharmaceuticals. 1 Analytical Method Validation: 1..1 Philosophy: Method validation is

More information

Alternative TSSs are co-regulated in single cells in the mouse brain

Alternative TSSs are co-regulated in single cells in the mouse brain Alternative TSSs are co-regulated in single cells in the mouse brain Kasper Karlsson, Peter Lönnerberg, Sten Linnarsson Corresponding author: Sten Linnarsson, Karolinska Institutet Review timeline: Submission

More information

Important Information for MCP Authors

Important Information for MCP Authors Guidelines to Authors for Publication of Manuscripts Describing Development and Application of Targeted Mass Spectrometry Measurements of Peptides and Proteins and Submission Checklist The following Guidelines

More information

Electronic Supplementary Information

Electronic Supplementary Information Electronic Supplementary Material (ESI) for Integrative Biology. This journal is The Royal Society of Chemistry 2015 Electronic Supplementary Information Table S1. Definition of quantitative cellular features

More information

Exploration and Analysis of DNA Microarray Data

Exploration and Analysis of DNA Microarray Data Exploration and Analysis of DNA Microarray Data Dhammika Amaratunga Senior Research Fellow in Nonclinical Biostatistics Johnson & Johnson Pharmaceutical Research & Development Javier Cabrera Associate

More information

Practical What & Where of Rigor and Reproducibility in the NIH Application. SIU School of Medicine Office of Grants & Contracts with Sophia Ran, PhD

Practical What & Where of Rigor and Reproducibility in the NIH Application. SIU School of Medicine Office of Grants & Contracts with Sophia Ran, PhD Practical What & Where of Rigor and Reproducibility in the NIH Application SIU School of Medicine Office of Grants & Contracts with Sophia Ran, PhD Recent Training Sessions NIH Regional Seminar Rigor and

More information

Supplementary Figure 1. Utilization of publicly available antibodies in different applications.

Supplementary Figure 1. Utilization of publicly available antibodies in different applications. Supplementary Figure 1 Utilization of publicly available antibodies in different applications. The fraction of publicly available antibodies toward human protein targets is shown with data for the following

More information

FIG S1: Calibration curves of standards for HPLC detection of Dopachrome (Dopac), Dopamine (DA) and Homovanillic acid (HVA), showing area of peak vs

FIG S1: Calibration curves of standards for HPLC detection of Dopachrome (Dopac), Dopamine (DA) and Homovanillic acid (HVA), showing area of peak vs FIG S1: Calibration curves of standards for HPLC detection of Dopachrome (Dopac), Dopamine (DA) and Homovanillic acid (HVA), showing area of peak vs amount of standard analysed. Each point represents the

More information

Reducing the number of animals used in behavioural genetic experiments using chromosome substitution strains

Reducing the number of animals used in behavioural genetic experiments using chromosome substitution strains 1 The Old School, Brewhouse Hill, Wheathampstead, Hertfordshire AL4 8AN, UK Animal Welfare 2006, 15: xxx-xxx ISSN 0962-7286 Reducing the number of animals used in behavioural genetic experiments using

More information

Nature Biotechnology: doi: /nbt Supplementary Figure 1. Mass spectrometry characterization of epoxide reactions.

Nature Biotechnology: doi: /nbt Supplementary Figure 1. Mass spectrometry characterization of epoxide reactions. Supplementary Figure 1 Mass spectrometry characterization of epoxide reactions. (a) Degree of amine reactivity of bovine serum albumin (BSA) with epoxide molecules having different numbers of epoxide groups:

More information

Writing Your Honors Thesis

Writing Your Honors Thesis Writing Your Honors Thesis Your thesis should be in the common scientific paper format using FIVE separate sections Abstract Introduction Materials and Methods Results Discussion Keep in mind----your thesis

More information

Real-time RT PCR. for identification of differentially expressed genes. (with Schizophrenia application) Rolf Sundberg, Stockholm Univ.

Real-time RT PCR. for identification of differentially expressed genes. (with Schizophrenia application) Rolf Sundberg, Stockholm Univ. Real-time RT PCR for identification of differentially expressed genes. (with Schizophrenia application) Rolf Sundberg, Stockholm Univ. Göteborg, May 2006 Real-time PCR for mrna quantitation Review paper

More information

Technical Assessment (TA) Summary Form (M00116)

Technical Assessment (TA) Summary Form (M00116) Technical Assessment (TA) Summary Form (M00116) Please complete the following 2 table summarization of the dossier. Table 1. Summary of Evidence Validation Element For each cell below, please provide the

More information

Reporting Checklist for Nature Neuroscience

Reporting Checklist for Nature Neuroscience Coesponding Autho: Manuscipt Numbe: Manuscipt Type: Yuki Oka NNA5991A Aticle Repoting Checklist fo Natue Neuoscience # Main Figues: 7 # Supplementay Figues: # Supplementay Tables: 0 # Supplementay Videos:

More information

Life Sciences Reporting Summary

Life Sciences Reporting Summary Life Sciences Reporting Summary Corresponding author(s): Craig M. Powell Initial submission Revised version Final submission Nature Research wishes to improve the reproducibility of the work that we publish.

More information

Detection of Histone Modifications at Specific Gene Loci in Single Cells in Histological Sections

Detection of Histone Modifications at Specific Gene Loci in Single Cells in Histological Sections Detection of Histone Modifications at Specific Gene Loci in Single Cells in Histological Sections Delphine Gomez; Laura L Shankman; Anh T Nguyen; Gary K Owens. Supplementary Figures 1-13 Supplementary

More information

Gene Expression Data Analysis

Gene Expression Data Analysis Gene Expression Data Analysis Bing Zhang Department of Biomedical Informatics Vanderbilt University bing.zhang@vanderbilt.edu BMIF 310, Fall 2009 Gene expression technologies (summary) Hybridization-based

More information

Post-expansion antibody delivery, after epitope-preserving homogenization.

Post-expansion antibody delivery, after epitope-preserving homogenization. Supplementary Figure 1 Post-expansion antibody delivery, after epitope-preserving homogenization. (a, b) Wide-field fluorescence images of Thy1-YFP-expressing mouse brain hemisphere slice before expansion

More information

SUPPLEMENTARY FIGURES

SUPPLEMENTARY FIGURES SUPPLEMENTARY FIGURES Supplementary Figure S1. Generation of a synaptobrevin2-mrfp knock-in mouse. (a) Targeting strategy of Syb2-mRFP knock-in mouse leaving the synaptobrevin2 gene locus intact except

More information

SensoLyte Anti-alpha-Synuclein Quantitative ELISA Kit (Human/Mouse/Rat) *Colorimetric*

SensoLyte Anti-alpha-Synuclein Quantitative ELISA Kit (Human/Mouse/Rat) *Colorimetric* Catalog # Kit Size SensoLyte Anti-alpha-Synuclein Quantitative ELISA Kit (Human/Mouse/Rat) *Colorimetric* AS-55550 One 96-well strip plate This kit is optimized to detect human/mouse/rat alpha-synuclein

More information

Parthanatos mediates AIMP2-activated age-dependent dopaminergic neuronal loss

Parthanatos mediates AIMP2-activated age-dependent dopaminergic neuronal loss SUPPLEMENTARY INFORMATION Parthanatos mediates AIMP2-activated age-dependent dopaminergic neuronal loss Yunjong Lee, Senthilkumar S. Karuppagounder, Joo-Ho Shin, Yun-Il Lee, Han Seok Ko, Debbie Swing,

More information

SensoLyte Anti-alpha-Synuclein Quantitative ELISA Kit (Rat) *Colorimetric*

SensoLyte Anti-alpha-Synuclein Quantitative ELISA Kit (Rat) *Colorimetric* SensoLyte Anti-alpha-Synuclein Quantitative ELISA Kit (Rat) *Colorimetric* Revision number: 1.3 Last updated: 1/15/18 Catalog # AS-55550-R Kit Size One 96-well strip plate This kit is optimized to detect

More information

Archives of Scientific Psychology Reporting Questionnaire for Manuscripts Describing Primary Data Collections

Archives of Scientific Psychology Reporting Questionnaire for Manuscripts Describing Primary Data Collections (Based on APA Journal Article Reporting Standards JARS Questionnaire) 1 Archives of Scientific Psychology Reporting Questionnaire for Manuscripts Describing Primary Data Collections JARS: ALL: These questions

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION SUPPLEMENTARY INFORMATION Multiplexed Profiling Of Single Extracellular Vesicles Kyungheon Lee 1#, Kyle Fraser 1#, Bassel Ghaddar 1, Katy Yang 1, Eunha Kim 1, Leonora Balaj 2, E. Antonio Chiocca 3, Xandra

More information

Lab 1: A review of linear models

Lab 1: A review of linear models Lab 1: A review of linear models The purpose of this lab is to help you review basic statistical methods in linear models and understanding the implementation of these methods in R. In general, we need

More information

Ngf (Rat) ELISA Kit. Catalog Number KA assays Version: 33. Intended for research use only.

Ngf (Rat) ELISA Kit. Catalog Number KA assays Version: 33. Intended for research use only. Ngf (Rat) ELISA Kit Catalog Number KA0401 96 assays Version: 33 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 Principle of the Assay...

More information

EECS730: Introduction to Bioinformatics

EECS730: Introduction to Bioinformatics EECS730: Introduction to Bioinformatics Lecture 14: Microarray Some slides were adapted from Dr. Luke Huan (University of Kansas), Dr. Shaojie Zhang (University of Central Florida), and Dr. Dong Xu and

More information

Calculation of Spot Reliability Evaluation Scores (SRED) for DNA Microarray Data

Calculation of Spot Reliability Evaluation Scores (SRED) for DNA Microarray Data Protocol Calculation of Spot Reliability Evaluation Scores (SRED) for DNA Microarray Data Kazuro Shimokawa, Rimantas Kodzius, Yonehiro Matsumura, and Yoshihide Hayashizaki This protocol was adapted from

More information

Estoril Education Day

Estoril Education Day Estoril Education Day -Experimental design in Proteomics October 23rd, 2010 Peter James Note Taking All the Powerpoint slides from the Talks are available for download from: http://www.immun.lth.se/education/

More information

Immunological Applications. Chapter 8: Background

Immunological Applications. Chapter 8: Background Immunological Applications Chapter 8: Background The Immune System Types of Immunity Innate The natural immunity present at birth Acquired A specific response to foreign substances. Some cells remember

More information

colorimetric sandwich ELISA kit datasheet

colorimetric sandwich ELISA kit datasheet colorimetric sandwich ELISA kit datasheet For the quantitative detection of human ENO2 concentrations in serum, plasma and cell culture supernatants. general information Catalogue Number Product Name Species

More information

Supplementary Methods. Li J.-Y. et al. Lewy bodies in grafted neurons in Parkinson s patients suggest host to. graft disease propagation

Supplementary Methods. Li J.-Y. et al. Lewy bodies in grafted neurons in Parkinson s patients suggest host to. graft disease propagation 1 Supplementary Methods Li J.-Y. et al. Lewy bodies in grafted neurons in Parkinson s patients suggest host to graft disease propagation Neural transplantation and clinical assessment Detailed information

More information

Resveratrol inhibits epithelial-mesenchymal transition of retinal. pigment epithelium and development of proliferative vitreoretinopathy

Resveratrol inhibits epithelial-mesenchymal transition of retinal. pigment epithelium and development of proliferative vitreoretinopathy Resveratrol inhibits epithelial-mesenchymal transition of retinal pigment epithelium and development of proliferative vitreoretinopathy Keijiro Ishikawa, 1,2 Shikun He, 2, 3 Hiroto Terasaki, 1 Hossein

More information

Gene expression: Microarray data analysis. Copyright notice. Outline: microarray data analysis. Schedule

Gene expression: Microarray data analysis. Copyright notice. Outline: microarray data analysis. Schedule Gene expression: Microarray data analysis Copyright notice Many of the images in this powerpoint presentation are from Bioinformatics and Functional Genomics by Jonathan Pevsner (ISBN -47-4-8). Copyright

More information

WT Day 90 after injections

WT Day 90 after injections Supplementary Figure 1 a Day 1 after injections Day 9 after injections Klf5 +/- Day 1 after injections Klf5 +/- Day 9 after injections BLM PBS b Day 1 after injections Dermal thickness (μm) 3 1 Day 9 after

More information

Jiali Li, Sukhvir P Mahal, Cheryl A Demczyk and Charles Weissmann

Jiali Li, Sukhvir P Mahal, Cheryl A Demczyk and Charles Weissmann Manuscript EMBOR-2011-35144 Mutability of prions Jiali Li, Sukhvir P Mahal, Cheryl A Demczyk and Charles Weissmann Corresponding author: Charles Weissmann, Scripps Florida Review timeline: Submission date:

More information

Mouse TNF alpha ELISA Kit

Mouse TNF alpha ELISA Kit Mouse TNF alpha ELISA Kit Catalog No. GWB-ZZD049 Size 96 wells/kit Sandwich ELISA kit for quantitative detection of mouse TNF alpha in cell culture supernates, serum and plasma(heparin, EDTA). Typical

More information

Designing a Complex-Omics Experiments. Xiangqin Cui. Section on Statistical Genetics Department of Biostatistics University of Alabama at Birmingham

Designing a Complex-Omics Experiments. Xiangqin Cui. Section on Statistical Genetics Department of Biostatistics University of Alabama at Birmingham Designing a Complex-Omics Experiments Xiangqin Cui Section on Statistical Genetics Department of Biostatistics University of Alabama at Birmingham 1/7/2015 Some slides are from previous lectures of Grier

More information

Supplementary Table 1. PCR amplification conditions for each primer pair. Primer sequence

Supplementary Table 1. PCR amplification conditions for each primer pair. Primer sequence - 1 - Supplementary Tables Supplementary Table 1. PCR amplification conditions for each primer pair Primer sequence FN1 S - CAAAGCAAGCCCGGTTGT AS - CGCTCCCACTGTTGATTTATCTG ITGα2 S - TTAGGTTACTCTGTGGCTGCAATT

More information

TheraLin. Universal Tissue Fixative Enabling Molecular Pathology

TheraLin. Universal Tissue Fixative Enabling Molecular Pathology TheraLin Universal Tissue Fixative Enabling Molecular Pathology TheraLin Universal Tissue Fixative Enabling Molecular Pathology Contents Page # TheraLin Universal Tissue Fixative 3 Introduction 5 Easy

More information

Supplementary Fig. 1 related to Fig. 1 Clinical relevance of lncrna candidate

Supplementary Fig. 1 related to Fig. 1 Clinical relevance of lncrna candidate Supplementary Figure Legends Supplementary Fig. 1 related to Fig. 1 Clinical relevance of lncrna candidate BC041951 in gastric cancer. (A) The flow chart for selected candidate lncrnas in 660 up-regulated

More information

Supplementary material

Supplementary material Supplementary material Tracking mesenchymal stem cell contributions to regeneration in an immunocompetent cartilage regeneration model Daniela Zwolanek, María Satué, Verena Proell, Josè R. Godoy, Kathrin

More information

MLN8237 induces proliferation arrest, expression of differentiation markers and

MLN8237 induces proliferation arrest, expression of differentiation markers and Supplementary Figure Legends Supplementary Figure 1 827 induces proliferation arrest, expression of differentiation markers and polyploidization of a human erythroleukemia cell line with the activating

More information

CytoGLOW. IKK-α/β. Colorimetric Cell-Based ELISA Kit. Catalog #: CB5358

CytoGLOW. IKK-α/β. Colorimetric Cell-Based ELISA Kit. Catalog #: CB5358 CytoGLOW IKK-α/β Colorimetric Cell-Based ELISA Kit Catalog #: CB5358 Please read the provided manual entirely prior to use as suggested experimental protocols may have changed. Research Purposes Only.

More information

Integrative Genomics 1a. Introduction

Integrative Genomics 1a. Introduction 2016 Course Outline Integrative Genomics 1a. Introduction ggibson.gt@gmail.com http://www.cig.gatech.edu 1a. Experimental Design and Hypothesis Testing (GG) 1b. Normalization (GG) 2a. RNASeq (MI) 2b. Clustering

More information

For quantitative detection of mouse EPO in cell culture supernates, serum, plasma (heparin, EDTA) and urine.

For quantitative detection of mouse EPO in cell culture supernates, serum, plasma (heparin, EDTA) and urine. Mouse EPO ELISA Kit Catalog No. EK0333 Size 96T(8 12 divisible strips) For quantitative detection of mouse EPO in cell culture supernates, serum, plasma (heparin, EDTA) and urine. Typical Data Obtained

More information

Supplementary Materials for

Supplementary Materials for www.sciencetranslationalmedicine.org/cgi/content/full/8/347/347ra94/d Supplementary Materials for n mirn-mediated therapy for S6 blocks IRES-driven translation of the N second cistron Yu Miyazaki, Xiaofei

More information

FFGWAS. Fast Functional Genome Wide Association AnalysiS of Surface-based Imaging Genetic Data

FFGWAS. Fast Functional Genome Wide Association AnalysiS of Surface-based Imaging Genetic Data FFGWAS Fast Functional Genome Wide Association AnalysiS of Surface-based Imaging Genetic Data Chao Huang Department of Biostatistics Biomedical Research Imaging Center The University of North Carolina

More information

Data normalization and standardization

Data normalization and standardization Data normalization and standardization Introduction Traditionally, real-time quantitative PCR (qpcr) has been used to measure changes in gene expression by producing millions of copies of specific, targeted

More information

Our web collection on statistics for biologists may be useful.

Our web collection on statistics for biologists may be useful. Reporting Summary Corresponding author(s): Charles E. Murry Nature Research wishes to improve the reproducibility of the work that we publish. This form provides structure for consistency and transparency

More information

QPCR ASSAYS FOR MIRNA EXPRESSION PROFILING

QPCR ASSAYS FOR MIRNA EXPRESSION PROFILING TECH NOTE 4320 Forest Park Ave Suite 303 Saint Louis, MO 63108 +1 (314) 833-9764 mirna qpcr ASSAYS - powered by NAWGEN Our mirna qpcr Assays were developed by mirna experts at Nawgen to improve upon previously

More information

Comparative Genomic Hybridization

Comparative Genomic Hybridization Comparative Genomic Hybridization Srikesh G. Arunajadai Division of Biostatistics University of California Berkeley PH 296 Presentation Fall 2002 December 9 th 2002 OUTLINE CGH Introduction Methodology,

More information